Main Causes of Death in Elderly Patients with Nephrotic Syndrome
Cardiovascular disease is the leading cause of death in elderly patients with nephrotic syndrome, accounting for 28% of deaths in primary nephrotic syndrome, followed by thromboembolic complications and infections, with overall mortality rates dramatically elevated compared to age-matched controls.
Mortality Risk Profile
Elderly patients with nephrotic syndrome face substantially elevated mortality compared to the general population. In patients ≥60 years with primary nephrotic syndrome, 3-year mortality reaches 24.9% versus only 9.4% in age-matched controls. For secondary nephrotic syndrome in this age group, the disparity is even more striking at 49.4% versus 8.1% 1.
Primary Causes of Death
1. Cardiovascular Disease (Leading Cause)
- Accounts for 28% of deaths in primary nephrotic syndrome, compared to 18% in the general population 1
- The risk of developing coronary heart disease is four times greater in nephrotic patients than age-matched controls 2
- Multiple contributing factors create this elevated risk:
- Hypercholesterolemia
- Hypertension
- Hypercoagulability
- Exposure to atherogenic drugs (particularly steroids)
2. Thromboembolic Complications
Nephrotic syndrome creates a hypercoagulable state with high rates of:
- Renal vein thrombosis: 29%
- Pulmonary embolism: 17-28%
- Deep vein thrombosis: 11% 2
These thromboembolic events represent a major contributor to mortality, particularly in elderly patients with limited physiologic reserve.
3. Infections
- Serious infections including septicemia are documented causes of death 3
- The immunosuppressive therapy required for treatment compounds infection risk
- Hypoalbuminemia itself increases susceptibility to infections
4. End-Stage Renal Disease (ESRD)
- 15% of patients progress to ESRD overall 1
- 3-year ESRD incidence: 8.4% in primary NS and 35.1% in secondary NS 1
- Patients with proteinuria >3.8 g/day have a 35% risk of ESRD within 2 years 2
Critical Prognostic Factors
Hypoalbuminemia is a powerful predictor of mortality: Each 1.0 g/dL decrease in serum albumin increases mortality odds by 137% and morbidity by 89% 2.
Protective factors that reduce both death and ESRD risk include:
- Early remission of proteinuria
- Absence of early acute kidney injury (AKI) 1
Clinical Implications
The elderly nephrotic population demonstrates more severe pathological changes including glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriolar hyalinization compared to younger patients 4. This structural damage, combined with age-related comorbidities, creates a perfect storm for adverse outcomes.
Common pitfall: Underestimating cardiovascular risk in elderly nephrotic patients. The excess cardiovascular mortality (28% vs 18% in general population) demands aggressive cardiovascular risk modification alongside nephrotic syndrome management.
The overall 3-year mortality of 21% in adult nephrotic syndrome 1 underscores the need for vigilant monitoring and aggressive management of cardiovascular risk factors, anticoagulation consideration for high-risk patients, infection prevention, and early intervention to achieve proteinuria remission.